CRANBURY, N.J., April 30, 2024 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced it will host a virtual KOL…
Month: April 2024
Continued strong year-over-year revenue growth in aerospace and defense Q1 2024 sales of $1.04 billion, up modestly from Q1 2023 Q1 2024 net income attributable to ATI of $66.1 million, or $0.46 per share Aerospace and defense represent $616 million of Q1 2024 sales, up from $576 million…
First Quarter 2024 Highlights: Total revenue increased 7% to $153.6 million Lindblad segment available guest nights increased 3% Lindblad segment net yield per available guest night increased 1% to $1,219 with higher pricing and occupancy of 76% Strong reservations for future travel with…
Fans can enter daily for a chance to win $5,000! CEDAR KNOLLS, N.J., April 30, 2024 /PRNewswire/ — Don’t pass up the chance to win big with the Eggland’s Best “Egg-ceptional Wellness” Sweepstakes! For the second year in a row, Eggland’s Best and Little League® have teamed up to fuel…
Flash Global’s Chief Customer Officer Examines Ways Flash Helps Customers Meet Service Level Agreements PARSIPPANY, N.J., April 30, 2024 /PRNewswire/ — Flash Global (Flash) is a global service logistics provider, and their Chief Customer Officer, Dan Silva, offers advice for equipment…
BEIJING, April 30, 2024 /PRNewswire/ — A report from People’s Daily Chinese President Xi Jinping will pay state visits to France, Serbia and Hungary from May 5 to 10. This will be the first visit to Europe by China’s head of state in nearly five years. Against the backdrop of…
1Q 2024 Diluted EPS of $1.29 1Q 2024 C&I adjusted diluted EPS of $1.45 1Q 2024 Managed receivables of $22.0 billion Raised quarterly dividend by 4% to $1.04 per share Repurchased 109 thousand shares for $5 million in 1Q NEW YORK, April 30, 2024 /PRNewswire/ — OneMain Holdings, Inc….
Revenue in Q1 2024 increased 26%, driven by Mounjaro, Zepbound, Verzenio and Jardiance. Pipeline progress included positive results from two Phase 3 trials of tirzepatide for obstructive sleep apnea; submission of mirikizumab for Crohn’s disease in the U.S. and EU; resubmission of…
NEW YORK, April 30, 2024 /PRNewswire/ — Foot Locker, Inc. (NYSE: FL), the New York-based specialty athletic retailer, plans to report financial results for its first quarter ended May 4, 2024, before the U.S. markets open on Thursday, May 30, 2024. A conference call is scheduled for the…
Future Market Insights (FMI) predicts a robust future for the scaffold technology market. This growth is primarily driven by advancements in tissue engineering and regenerative medicine. As these fields develop, demand for innovative scaffold materials to aid tissue repair and…
